Wound Debridement Products Market Growth Owing To Rising Prevalence of Chronic Wounds
The wound debridement products market is estimated to be valued at US$ 779.9 Mn in 2023 and is expected to exhibit a CAGR of 9.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Wound debridement products are primarily used for the removal of dead, damaged, infected, or excessive amounts of tissues, foreign material and biofilm from chronic or acute wounds to promote healing. Common debridement products include hydrogels, gauze, ointments, pads and creams. The products are either used for autolytic debridement which involves maintaining a moist wound environment or surgical debridement performed by healthcare professionals. Wound debridement helps improve absorption of topical medications, reduces inflammation and pain, and allows assessment of underlying wound.
Market Dynamics:
One of the major drivers expected to boost the market growth includes rising prevalence of chronic wounds such as diabetic foot ulcers, venous leg ulcers and pressure ulcers. As per the International Diabetes Federation, in 2021, around 643 million adults were living with diabetes globally which is projected to reach 783 million by 2045. Diabetic foot ulcers are a common complication of diabetes which requires timely debridement to prevent infection and risk of amputation. Moreover, increasing geriatric population also fuels the incidence of chronic wounds attributed to impaired healing and reduced mobility. According to the United Nations, by 2050, one in six people in the world will be over age 65, up from one in 11 in 2019. This age group is more susceptible to venous insufficiency and pressure ulcers due to skin fragility.
Another factor contributing to market growth is the growing preference of minimally invasive debridement procedures such as hydrogel debridement and larval therapy over traditional surgical methods associated with pain, high costs and risk of infection. Technological advancements have led to development of safe and effective advanced debridement dressings capable of selective removal of necrotic tissues without damage to healthy skin cells. Ongoing R&D activities focused on introducing novel biodegradable and biocompatible polymeric wound dressings are also boosting adoption.
SWOT Analysis
Strength: Wound debridement products provide expedited healing and prevent infection. Advances in technologies such as hydrogel and ultrasound therapy have enhanced healing outcomes. Growing awareness about wound management bolsters the market.
Weakness: High costs associated with advanced products limit widespread adoption. Lack of reimbursement policies in developing regions pose challenges.
Opportunity: Rising prevalence of diabetes and associated foot ulcers present opportunities. Increasing number of accident and burn cases will augment demand. Expanding healthcare infrastructure in emerging nations provide scope.
Threats: Availability of alternative traditional wound care methods can deter demand. Stringent regulations delay product approvals.
Key Takeaways
The global wound debridement products market is expected to witness high growth, exhibiting CAGR of 9.2% over the forecast period, due to increasing prevalence of diabetes and road accidents. By 2030, the market size is estimated to reach US$ 1.5 Bn.
Regional analysis: North America dominated the market with over 35% share in 2023 due to supportive reimbursement policies and availability of advanced products. Asia Pacific shows lucrative growth aided by improving access to healthcare in India and China.
Key players operating in the wound debridement products are DeRoyal Industries, Inc., Monarch Labs, Zimmer Biomet, Bactiguard AB, Bioventus, Convatec Group PLC, B. Braun SE, Scapa Healthcare, PAUL HARTMANN AG, ACRO Biomedical Co., Ltd., Medline Industries, LP., Organogenesis Inc., Cardinal Health, Human Biosciences Inc. Key players are focused on developing novel solutions and expanding geographical presence to consolidate their market shares.
